Bimal Malhotra

2.0k total citations · 1 hit paper
69 papers, 1.5k citations indexed

About

Bimal Malhotra is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Urology. According to data from OpenAlex, Bimal Malhotra has authored 69 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pharmacology, 15 papers in Pediatrics, Perinatology and Child Health and 14 papers in Urology. Recurrent topics in Bimal Malhotra's work include Pharmacogenetics and Drug Metabolism (18 papers), Urinary Bladder and Prostate Research (14 papers) and Pain Management and Opioid Use (10 papers). Bimal Malhotra is often cited by papers focused on Pharmacogenetics and Drug Metabolism (18 papers), Urinary Bladder and Prostate Research (14 papers) and Pain Management and Opioid Use (10 papers). Bimal Malhotra collaborates with scholars based in United States, United Kingdom and Japan. Bimal Malhotra's co-authors include Nolan Wood, Kuan Gandelman, Richard Sachse, Brahma N. Singh, Martin C. Michel, Paul Glue, Gary G. Kay, Hernán Valdez, Rodney Sinclair and Ileana A. Ionita and has published in prestigious journals such as New England Journal of Medicine, Pain and Journal of Controlled Release.

In The Last Decade

Bimal Malhotra

68 papers receiving 1.5k citations

Hit Papers

Abrocitinib versus Placebo or Dupilumab for Atopic Dermat... 2021 2026 2022 2024 2021 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bimal Malhotra United States 20 463 428 330 243 205 69 1.5k
A. Buntinx Belgium 14 68 0.1× 39 0.1× 18 0.1× 23 0.1× 62 0.3× 23 1.0k
Kathleen Butler United States 25 15 0.0× 32 0.1× 142 0.4× 74 0.3× 18 0.1× 67 3.1k
Mathew George Australia 15 16 0.0× 87 0.2× 61 0.2× 92 0.4× 8 0.0× 90 1.0k
Alan G. Meehan United States 21 751 1.6× 260 0.6× 131 0.4× 113 0.5× 1 0.0× 39 1.6k
Timothy H. Wilson United States 20 1.2k 2.6× 462 1.1× 132 0.4× 126 0.5× 1 0.0× 50 2.3k
Peter Seideman Sweden 21 11 0.0× 311 0.7× 21 0.1× 39 0.2× 26 0.1× 49 1.1k
Alfonso E. Bello United States 14 20 0.0× 334 0.8× 16 0.0× 28 0.1× 16 0.1× 24 1.4k
Ying Zhou China 22 28 0.1× 71 0.2× 13 0.0× 105 0.4× 6 0.0× 103 1.4k
Israeli A. Jaffe United States 20 8 0.0× 304 0.7× 35 0.1× 70 0.3× 20 0.1× 36 1.2k
M.A. Barradas United Kingdom 23 12 0.0× 48 0.1× 17 0.1× 126 0.5× 56 0.3× 72 1.7k

Countries citing papers authored by Bimal Malhotra

Since Specialization
Citations

This map shows the geographic impact of Bimal Malhotra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bimal Malhotra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bimal Malhotra more than expected).

Fields of papers citing papers by Bimal Malhotra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bimal Malhotra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bimal Malhotra. The network helps show where Bimal Malhotra may publish in the future.

Co-authorship network of co-authors of Bimal Malhotra

This figure shows the co-authorship network connecting the top 25 collaborators of Bimal Malhotra. A scholar is included among the top collaborators of Bimal Malhotra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bimal Malhotra. Bimal Malhotra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, X., Martin E. Dowty, Vu Le, et al.. (2024). Assessment of the Effects of Abrocitinib on the Pharmacokinetics of Probe Substrates of Cytochrome P450 1A2, 2B6 and 2C19 Enzymes and Hormonal Oral Contraceptives in Healthy Individuals. European Journal of Drug Metabolism and Pharmacokinetics. 49(3). 367–381. 3 indexed citations
2.
Kitta, Takeya, Amanda Darekar, Bimal Malhotra, et al.. (2022). Fesoterodine treatment of pediatric patients with neurogenic detrusor overactivity: A 24-week, randomized, open-label, phase 3 study. Journal of Pediatric Urology. 19(2). 175.e1–175.e10. 2 indexed citations
3.
Wang, Xiaoxing, Martin E. Dowty, Svitlana Tatulych, et al.. (2022). Assessment of the Effects of Inhibition or Induction of CYP2C19 and CYP2C9 Enzymes, or Inhibition of OAT3, on the Pharmacokinetics of Abrocitinib and Its Metabolites in Healthy Individuals. European Journal of Drug Metabolism and Pharmacokinetics. 47(3). 419–429. 22 indexed citations
5.
Malhotra, Bimal, et al.. (2015). Effects of Ethanol on the Pharmacokinetics of Extended-Release Oxycodone with Sequestered Naltrexone (ALO-02). Clinical Drug Investigation. 35(4). 267–274. 8 indexed citations
7.
Knebel, William, Marc R. Gastonguay, Bimal Malhotra, et al.. (2013). Population Pharmacokinetics of Atorvastatin and Its Active Metabolites in Children and Adolescents With Heterozygous Familial Hypercholesterolemia: Selective Use of Informative Prior Distributions from Adults. The Journal of Clinical Pharmacology. 53(5). 505–516. 17 indexed citations
8.
Kay, Gary G., et al.. (2012). Evaluation of Cognitive Function in Healthy Older Subjects Treated with Fesoterodine. Postgraduate Medicine. 124(3). 7–15. 52 indexed citations
9.
Kay, Gary G., et al.. (2011). Evaluation of Cognitive Function in Healthy Older Adults Treated With Fesoterodine. Neurourology and Urodynamics. 30(6). 3 indexed citations
10.
Chiba, Kōji, et al.. (2011). Pharmacokinetics of Tolterodine in Japanese and Koreans: Physiological and Stochastic Assessment of Ethnic Differences. Drug Metabolism and Pharmacokinetics. 26(3). 236–241. 9 indexed citations
11.
Malhotra, Bimal, Richard Sachse, & Nolan Wood. (2009). Influence of food on the pharmacokinetic profile of fesoterodine. International Journal of Clinical Pharmacology and Therapeutics. 47(6). 384–390. 11 indexed citations
12.
Malhotra, Bimal, Richard Sachse, & Nolan Wood. (2009). Evaluation of drug–drug interactions with fesoterodine. European Journal of Clinical Pharmacology. 65(6). 551–560. 25 indexed citations
13.
Malhotra, Bimal, Nolan Wood, & Richard Sachse. (2009). Influence of age, gender, and race on pharmacokinetics, pharmacodynamics, and safety of fesoterodine. International Journal of Clinical Pharmacology and Therapeutics. 47(9). 570–578. 29 indexed citations
14.
Malhotra, Bimal, Zhiwei Guan, Nolan Wood, & Kuan Gandelman. (2008). Pharmacokinetic profile of fesoterodine. International Journal of Clinical Pharmacology and Therapeutics. 46(11). 556–563. 57 indexed citations
15.
Parker, John D., Bradley A. Bart, David J. Webb, et al.. (2007). Safety of intravenous nitroglycerin after administration of sildenafil citrate to men with coronary artery disease: A double-blind, placebo-controlled, randomized, crossover trial*. Critical Care Medicine. 35(8). 1863–1868. 20 indexed citations
16.
Malhotra, Bimal, Paul Glue, Kevin Sweeney, et al.. (2007). Thorough QT Study with Recommended and Supratherapeutic Doses of Tolterodine. Clinical Pharmacology & Therapeutics. 81(3). 377–385. 64 indexed citations
17.
Singh, Brahma N. & Bimal Malhotra. (2004). Effects of Food on the Clinical Pharmacokinetics of Anticancer Agents. Clinical Pharmacokinetics. 43(15). 1127–1156. 99 indexed citations
18.
Iyer, Ramaswamy A., Bimal Malhotra, Sanaullah Khan, et al.. (2003). Comparative Biotransformation of Radiolabeled [14C]Omapatrilat and Stable-labeled [13C2]Omapatrilat after Oral Administration to Rats, Dogs, and Humans. Drug Metabolism and Disposition. 31(1). 67–75. 13 indexed citations
19.
Malhotra, Bimal, et al.. (2001). Percutaneous Absorption and Pharmacokinetics of Eflornithine HCl 13.9% Cream in Women with Unwanted Facial Hair. The Journal of Clinical Pharmacology. 41(9). 972–978. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026